# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Multiple sclerosis

MS
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 440 results.
Nutritional Approaches in Multiple Sclerosis
Status: Recruiting
Last Changed: Nov 29, 2018
First Received: Apr 25, 2018
Disease(s): Multiple Sclerosis
Intervention(s): ketogenic diet, Intermittent therapeutical fasting, Active comparator
Locations: Charité - Universitätsmedizin Berlin, Berlin, Germany
Novel Nanosensor Array for Detection of Volatile Biomarkers From Skin in Multiple Sclerosis
Status: Not yet recruiting
Last Changed: Sep 04, 2019
First Received: Aug 30, 2019
Disease(s): Multiple Sclerosis
Intervention(s): Diagnosis, skin volatile organic compounds (VOCs)
Swiss Multiple Sclerosis Registry
Status: Recruiting
Last Changed: Sep 18, 2019
First Received: Dec 02, 2016
Disease(s): Multiple Sclerosis
Locations: University of Zurich; Epidemiology, Biostatistics & Prevention Institute, Zurich, Switzerland
A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil
Status: Recruiting
Last Changed: Aug 29, 2017
First Received: Mar 22, 2017
Disease(s): Multiple Sclerosis
Intervention(s): anti-aquaporin-4 antibody, anti-myelin oligodendrocyte glycoprotein
Locations: Universidade Federal de Uberlândia, Uberlandia, MG, Brazil
Hospital da Restauração de Recife, Recife, PE, Brazil
Instituto de Neurologia de Curitiba, Curitiba, PR, Brazil
Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
Santa Casa de Misericordia de Porto Alegre, Porto Alegre, RS, Brazil
... and 4 other locations.
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Jan 21, 2016
Disease(s): Multiple Sclerosis
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Physical Telerehabilitation in Multiple Sclerosis
Status: Recruiting
Last Changed: Jul 27, 2017
First Received: Jul 27, 2017
Disease(s): Multiple Sclerosis
Intervention(s): Home telerehabilitation, Usual Care
Locations: Columbia University Medical Center, New York, New York, United States
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: Nov 12, 2018
Disease(s): Multiple Sclerosis (MS)
Intervention(s): elezanumab, placebo
Locations: University of Alabama at Birmingham - Main /ID# 204618, Birmingham, Alabama, United States
St. Josephs Hosp and Med Ctr /ID# 204197, Phoenix, Arizona, United States
Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 204249, Berkeley, California, United States
The Research Ctr Southern CA /ID# 204269, Carlsbad, California, United States
Vladimir Royter MD /ID# 204392, Hanford, California, United States
... and 46 other locations.
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis
Status: Recruiting
Last Changed: Aug 15, 2019
First Received: Nov 12, 2018
Disease(s): Multiple Sclerosis (MS)
Intervention(s): elezanumab, placebo
Locations: St. Josephs Hosp and Med Ctr /ID# 202809, Phoenix, Arizona, United States
Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 202448, Berkeley, California, United States
The Research Center of Southern California /ID# 202802, Carlsbad, California, United States
Vladimir Royter MD /ID# 202483, Hanford, California, United States
Stanford MS Center /ID# 202445, Palo Alto, California, United States
... and 35 other locations.
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for Multiple Sclerosis (MS)
Status: Recruiting
Last Changed: Sep 02, 2019
First Received: May 23, 2019
Disease(s): Multiple Sclerosis
Intervention(s): Cladribine
Locations: Please Contact U.S. Medical Information, Rockland, Massachusetts, United States
Empire Neurology, PC - Empire Neurology PC, Latham, New York, United States
Omrf (11523), Oklahoma City, Oklahoma, United States
Please Contact the Communication Center, Darmstadt, Germany
Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM
Status: Recruiting
Last Changed: Aug 09, 2019
First Received: Dec 24, 2018
Disease(s): Multiple Sclerosis
Intervention(s): Ocrelizumab
Locations: Juan Ignacio Rojas, Buenos Aires, Argentina
Juan Ignacio Rojas, Buenos Aires, Argentina
Juan Ignacio Rojas, Buenos Aires, Argentina
Edgard Carnero, Buenos Aires, Argentina